Companies that own uniQure N.V.
Fidelity Management & Research Co.
3,598,681
9.69%
1,321,283
0.02%
06/30/2018
Nantahala Capital Management LLC
1,756,439
4.73%
-83,335
5.35%
06/30/2018
Fidelity (Canada) Asset Management ULC
1,736,023
4.67%
860,623
0.11%
06/30/2018
OppenheimerFunds, Inc.
1,681,302
4.53%
1,681,302
0.04%
06/30/2018
Redmile Group LLC
1,624,400
4.37%
1,624,400
2.13%
06/30/2018
Perceptive Advisors LLC
1,444,628
3.89%
50,000
1.4%
06/30/2018
Federated Global Investment Management Corp.
1,091,280
2.94%
173,281
0.33%
06/30/2018
683 Capital Management LLC
1,050,000
2.83%
0
5.08%
06/30/2018
Consonance Capital Management LP
1,045,065
2.81%
0
2.37%
06/30/2018
Eventide Asset Management LLC
754,050
2.02%
419,050
1.22%
06/30/2018
| Address |
Paasheuvelweg 25a
Amsterdam Noord-Holland 1105 BP
Netherlands
|
|
Employees
|
- |
| Website |
http://www.uniqure.com |
| Updated |
07/08/2019 |
| uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded on January 9, 2012 and is headquartered in Amsterdam, the Netherlands. |
